Full text
Main Subject
Language
Journal
Year
Country
1.Safety and Efficacy of a Novel, Fenestrated Aortic Arch Stent Graft with a Preloaded Catheter for Supraaortic Arch Vessels: An Experimental Study in Swine.
Sang Pil KIM ; Han Cheol LEE ; Tae Sik PARK ; Jin Hee AHN ; Hye Won LEE ; Jong Ha PARK ; Junhyok OH ; Jung Hyun CHOI ; Kwang Soo CHA
Journal of Korean Medical Science 2015;30(4):426-434
Thoracic endovascular aortic repair (TEVAR) shows limitations in cases in which the aortic pathology involves the aortic arch. The study aims were to test a fenestrated aortic arch stent graft (FASG) with a preloaded catheter for the supraaortic arch vessels and to perform a preclinical study in swine to evaluate the safety and efficacy of this device. Six FASGs with 1 preloaded catheter and 5 FASGs with 2 preloaded catheters were advanced through the iliac artery in 11 swines. The presence of endoleaks and the patency and deformity of the grafts were examined with computed tomography (CT) at 4 weeks postoperatively. A postmortem examination was performed at 8 weeks. The mean procedure time for the one and two FASG groups was 30.2 (27.9-34.5) min and 43.1 (39.2-53.7) min. The mean time for the selection of the carotid artery was 4.8 (4.2-5.5) min and 6.2 (4.6-9.4) min. Major adverse event was observed in one of 11 pigs. One pig died at 4 weeks likely because of the effects of the high dose of ketamine, while the remaining 10 pigs survived 8-week. For both the one and two FASG groups, no endoleaks, no disconnection, no occlusion of the stent grafts were observed in the CT findings and the postmortem gross findings. The procedure with the FASG could be performed safely in a relatively short procedure time and involved an easy technique. The FASG is found to be safe and convenient in this preclinical study with swine.
Animals
;
Aorta, Thoracic/*surgery
;
Catheters
;
Endovascular Procedures/adverse effects/*instrumentation
;
*Stents
;
Swine
;
Tomography, X-Ray Computed
2.Efficacy of different types of self-expandable stents in carotid artery stenting for carotid bifurcation stenosis.
Ya-min LIU ; Hao QIN ; Bo ZHANG ; Yu-jing WANG ; Jun FENG ; Xiang WU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(1):95-98
Both open and closed loop self-expandable stents were used in carotid artery stenting (CAS) for carotid bifurcation stenosis. We sought to compare the efficacy of two types of stents in CAS. The data of 212 patients treated with CAS (42 and 170 cases implanted with closed and open loop stents, respectively) for carotid bifurcation stenosis and distal filtration protection devices were retrospectively analyzed. Between closed and open loop stents, there were no significant differences in hospitalization duration, NIHSS score before and after the treatment, stenosis at 12th month, and cumulative incidence of primary endpoint events within 30 days or from the 31st day to the 12th month; while there were significant differences in hemodynamic changes and rate of difficulty in recycling distal filtration protection devices. Use of open vs. closed loop stents for carotid bifurcation stenosis seems to be associated with similar incidence of complications, except for greater rate of hemodynamic changes and lower rate of difficulty in recycling the distal filtration protection devices.
Adult
;
Aged
;
Aged, 80 and over
;
Carotid Arteries
;
surgery
;
Carotid Stenosis
;
surgery
;
Endovascular Procedures
;
adverse effects
;
instrumentation
;
methods
;
Female
;
Hemodynamics
;
Humans
;
Male
;
Middle Aged
;
Postoperative Complications
;
Self Expandable Metallic Stents
;
adverse effects
3.Endovascular Recanalization of a Thrombosed Native Arteriovenous Fistula Complicated with an Aneurysm: Technical Aspects and Outcomes.
Su Yeon AHN ; Young Ho SO ; Young Ho CHOI ; In Mok JUNG ; Jung Kee CHUNG
Korean Journal of Radiology 2015;16(2):349-356
OBJECTIVE: To evaluate the technical aspects and outcomes of endovascular recanalization of a thrombosed native arteriovenous fistula (AVF) complicated with an aneurysm. MATERIALS AND METHODS: Sixteen patients who had a thrombosed AVF complicated with an aneurysm (two radiocephalic and 14 brachiocephalic) were included in this study. Recanalization procedures were performed by mechanical thrombectomy using the Arrow-Trerotola percutaneous thrombectomy device and adjunctive treatments. We evaluated dose of thrombolytic agent, underlying stenosis, procedure time, technical and clinical success, and complications. The primary and secondary patency rates were calculated using the Kaplan-Meier analysis. RESULTS: The thrombolytic agents used were 100000 U urokinase mixed with 500 IU heparin (n = 10) or a double dose of the mixture (n = 6). The thrombi in aneurysms were removed in all but two patients with non-flow limiting residual thrombi. One recanalization failure occurred due to a device failure. Aspiration thrombectomy was performed in 87.5% of cases (n = 14). Underlying stenoses were found in the outflow draining vein (n = 16), arteriovenous anastomosis or juxtaanastomosis area (n = 5), and the central vein (n = 3). Balloon angioplasty was performed for all stenoses in 15 patients. Two patients with a symptomatic central vein stenosis underwent insertion of a stent after balloon angioplasty. Mean procedure time was 116.3 minutes. Minor extravasation (n = 1) was resolved by manual compression. Both technical and clinical success rates were 93.8% (n = 15). The primary patency rates at 3, 6, and 12 months were 70.5%, 54.8%, and 31.3%, respectively. The secondary patency rates at 3, 6, and 12 months were 70.5%, 70.5%, and 47.0%, respectively. CONCLUSION: Thrombosed AVF complicated with an aneurysm can be successfully recanalized, and secondary patency can be prolonged with endovascular treatment.
Aged
;
Aged, 80 and over
;
Aneurysm/complications/*surgery
;
Angioplasty, Balloon
;
Arteriovenous Fistula/*surgery
;
Arteriovenous Shunt, Surgical/adverse effects
;
Constriction, Pathologic/complications
;
Endovascular Procedures
;
Equipment Failure
;
Female
;
Fibrinolytic Agents/therapeutic use
;
Heparin/therapeutic use
;
Humans
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Retrospective Studies
;
Stents/adverse effects
;
Thrombectomy/instrumentation/*methods
;
Thrombosis/etiology/*surgery
;
Urokinase-Type Plasminogen Activator/therapeutic use
;
Vascular Patency
;
Veins